Patient Pathfinder: Clinical Trials
Clinical Trials for Non Hodgkin Lymphoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 514 active Non Hodgkin Lymphoma trials
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Study Type: Interventional Phase 2
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Study Type: Interventional Phase 1
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Study Type: Interventional Phase 2
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin’s Lymphoma
Study Type: Interventional Phase 1
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Study Type: Interventional Phase 1
A Study to Assess Safety and Efficacy of CHO-H01 in Subjects With Refractory or Relapsed Non-Hodgkin’s Lymphoma
Study Type: Interventional Phase 1
Impact of Respiratory Training in Lymphoma Survivors
Study Type: Interventional
There are 514 active Non Hodgkin Lymphoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now